Compound heterozygous UGT1A1*28 and UGT1A1*6 or single homozygous UGT1A1*28 are major genotypes associated with Gilbert ? s syndrome in Chinese Han people

被引:6
|
作者
Zhang, Meng [1 ]
Wang, Hongwu [1 ]
Huang, Yuancheng [1 ,2 ]
Xu, Xin [1 ]
Liu, Wei [1 ]
Ning, Qin [1 ]
Chen, Tao [1 ]
Qi, Junying [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept & Inst Infect Dis, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Phys Examinat Ctr, Wuhan, Hubei, Peoples R China
关键词
Hyperbilirubinemia; Genotype; Chinese people; CRIGLER-NAJJAR-SYNDROME; SERUM BILIRUBIN CONCENTRATIONS; UGT1A1; GENE-MUTATIONS; INHERITED DISORDERS; NEONATAL HYPERBILIRUBINEMIA; UDP-GLUCURONOSYLTRANSFERASE-1; VARIANTS; PROMOTER; POLYMORPHISM; METABOLISM;
D O I
10.1016/j.gene.2021.145526
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Gilbert?s syndrome (GS) is a mild condition characterized by periods of hyperbilirubinemia, which results in variations in the UDP-glucuronosyltransferase 1 (UGT1A1) gene. Variant genotypes of UGT1A1 vary in different populations in the world. The present study aimed to determine the genotype of the UGT1A1 promoter and exon that are related to the serum total bilirubin (STB) level in the Chinese Han population. A total of 120 individuals diagnosed with GS (GS group) and 120 healthy individuals (non-GS group) were enrolled. Routine blood, liver function tests, and antibodies associated with autoimmune liver diseases were assessed. Blood samples were collected for DNA purification. Sequencing of the UGT1A1 promoter and exons was conducted for post segment amplification by PCR. Compound heterozygous UGT1A1*28 and UGT1A1*6 (25/120, 20.83%), single homozygous UGT1A1*28 (24/120, 20.00%) and single heterozygous UGT1A1*6 (18/120, 15.00%) were the most frequent genotypes in the GS group. However, single heterozygous UGT1A1*6 (30/120, 25.00%) and single heterozygous UGT1A1*28 (19/120, 15.83%) were the most frequent genotypes in the non-GS group. Further, the frequencies of single homozygous UGT1A1*28, compound heterozygous UGT1A1*28 and UGT1A1*6, and compound heterozygous UGT1A1*28, UGT1A1*6 and UGT1A1*27 were significantly higher in the GS group than those in the non-GS group. The STB levels of GS patients with the homozygous UGT1A1*28 genotype were remarkably higher than those of patients with other genotypes. Homozygous UGT1A1*28 and heterozygous UGT1A1*6 variants were associated with the highest and lowest risks of hyperbilirubinemia, respectively. Our study revealed that compound heterozygous UGT1A1*28 and UGT1A1*6, or single homozygous UGT1A1*28 are major genotypes associated with GS in Chinese Han people. These findings might facilitate the precise genomic diagnosis of Gilbert?s syndrome.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Effects of Shengjiangxiexin decoction on irinotecan-induced toxicity in patients with UGT1A1*28 and UGT1A1*6 polymorphisms
    Deng Bo
    Jia Liqun
    Tan Huangying
    Lou Yanni
    Li Xue
    Li Yuan
    Yu Lili
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2017, 37 (01) : 35 - 42
  • [22] Meta-analysis revisiting the influence of UGT1A1*28 and UGT1A1*6 on irinotecan safety in colorectal cancer patients
    Thu Nguyen, Cuc Thi
    Minh Thuy, Nguyen Thi
    Huong, Phung Thanh
    PHARMACOGENOMICS, 2024, 25 (10-11) : 469 - 477
  • [23] Frequency of the UGT1A1*28 Polymorphism in a Romanian Cohort of Gilbert Syndrome Individuals
    Radoi, Viorica E.
    Ursu, Radu I.
    Poenaru, Elena
    Arsene, Cosmin
    Bohiltea, Camil L.
    Bohiltea, Roxana
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2017, 26 (01) : 25 - 28
  • [24] UGT1A1*28 and Breast Cancer: Increased Risk for Gilbert's Syndrome Patients
    Francisco, A. R. F.
    Gomes, D. B. D.
    Souza, M. M. T.
    Martini, R. R.
    Maciel, G. A. R.
    Ono-Nita, S. K.
    Goes, J. C. S.
    Baracat, E. C.
    CANCER RESEARCH, 2010, 70
  • [25] Spectrum of UGT1A1 variations in chinese patients with Gilbert's syndrome
    Tan, Wenting
    Zhang, Wenyan
    Zhu, Yan
    Dan, Yunjie
    Xiang, Xiaomei
    Wang, Xiuhua
    Zhou, Yi
    Guo, Yanzhi
    Xia, Jie
    Deng, Guohong
    JOURNAL OF HEPATOLOGY, 2024, 80 : S701 - S702
  • [26] Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients
    Fei-fei Han
    Chang-long Guo
    Dan Yu
    Jin Zhu
    Li-li Gong
    Guang-run Li
    Ya-li Lv
    He Liu
    Guang-yu An
    Li-hong Liu
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 779 - 788
  • [27] Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients
    Han, Fei-fei
    Guo, Chang-long
    Yu, Dan
    Zhu, Jin
    Gong, Li-li
    Li, Guang-run
    Lv, Ya-li
    Liu, He
    An, Guang-yu
    Liu, Li-hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 779 - 788
  • [28] Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1☆28 and/or UGT1A1☆6 polymorphisms
    Satoh, Taroh
    Ura, Takashi
    Yamada, Yasuhide
    Yamazaki, Kentaro
    Tsujinaka, Toshimasa
    Munakata, Masaki
    Nishina, Tomohiro
    Okamura, Shu
    Esaki, Taito
    Sasaki, Yasutsuna
    Koizumi, Wasaburo
    Kakeji, Yoshihiro
    Ishizuka, Naoki
    Hyodo, Ichinosuke
    Sakata, Yuh
    CANCER SCIENCE, 2011, 102 (10) : 1868 - 1873
  • [29] Variation in UGT1A1 activity in Gilbert's syndrome - Reply
    Peters, WHM
    Raijmakers, MTM
    Steegers, EAP
    Jansen, PLM
    JOURNAL OF HEPATOLOGY, 2001, 34 (04) : 637 - 638
  • [30] UGT1A1*28 polymorphism in ovarian cancer patients
    Cecchin, E
    Russo, A
    Corona, G
    Campagnutta, E
    Martella, L
    Boiocchi, M
    Toffoli, G
    ONCOLOGY REPORTS, 2004, 12 (02) : 457 - 462